LNP Formulation Development: From Lipid Screening to cGMP Manufacturing Explore BioCina’s LNP formulation development and manufacturing capabilities, from lipid screening and encapsulation to scalable cGMP production. Discover how our…
cGMP Plasmid DNA Manufacturing: Process, Scale and CDMO Capabilities BioCina is a cGMP pDNA manufacturing CDMO providing scalable E. coli microbial fermentation (400mL–500L) for mRNA templates & viral vectors.…
Scaling cGMP mRNA Drug Substance Manufacturing: Process, Quality, and CDMO Selection Learn how an integrated mRNA drug substance CDMO streamlines IVT, LNP formulation, and tech transfer. Explore BioCina’s Adelaide suite capabilities.…
Selecting a cGMP Microbial Fermentation CDMO: Key Capabilities & Considerations Microbial fermentation remains one of the most established platforms for microbial drug substance manufacturing……
What Is Cytotoxic Drug Manufacturing? Cytotoxic drug manufacturing is a specialized area of pharmaceutical production focused on the safe handling, formulation, and fill-finish of compounds…
Why Blow Fill Seal Technology Is Growing in Pharmaceutical Manufacturing Blow fill seal technology is one of the fastest-growing segments in sterile pharmaceutical manufacturing. A single continuous automated process forms,…
What Is an Isolator Filling Workcell? An isolator filling workcell is a robotic, closed-system aseptic filling platform designed to eliminate human presence from the critical fill…
Agility in Biomanufacturing: The Key to Overcoming Uncertainty In today’s biopharma landscape, resilience isn’t enough — CDMOs must also be agile. Agility enables clients to adjust quickly to…
What’s next for mRNA after COVID-19? The pandemic proved that mRNA-based vaccines could be developed, manufactured, and distributed globally in record time. But the real promise…